tradingkey.logo

IRadimed Corp

IRMD
查看详细走势图
97.060USD
+0.460+0.48%
收盘 12/24, 13:00美东报价延迟15分钟
1.23B总市值
58.23市盈率 TTM

IRadimed Corp

97.060
+0.460+0.48%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.48%

5天

+3.23%

1月

+7.47%

6月

+60.48%

今年开始到现在

+76.47%

1年

+79.04%

查看详细走势图

TradingKey IRadimed Corp股票评分

单位: USD 更新时间: 2025-12-24

操作建议

IRadimed Corp当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名29/206位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价99.00。中期看,股价处于上升通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

IRadimed Corp评分

相关信息

行业排名
29 / 206
全市场排名
100 / 4562
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 2 位分析师
买入
评级
99.000
目标均价
+3.69%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

IRadimed Corp亮点

亮点风险
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
业绩高增长
公司营业收入稳步增长,连续3年增长37.41%
业绩增长期
公司处于发展阶段,最新年度总收入73.24M美元
利润高增长
公司净利润处于行业前列,最新年度总收入73.24M美元
高分红
公司属于高分红公司,最新股息支付率29.64%
估值高估
公司最新PE估值58.23,处于3年历史高位
机构减仓
最新机构持股7.41M股,环比减少11.47%
CI 精选加拿大股票基金持仓
明星投资者CI 精选加拿大股票基金持仓,最新持仓市值27.00

IRadimed Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

IRadimed Corp简介

IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
公司代码IRMD
公司IRadimed Corp
CEOSusi (Roger)
网址https://www.iradimed.com/

常见问题

IRadimed Corp(IRMD)的当前股价是多少?

IRadimed Corp(IRMD)的当前股价是 97.060。

IRadimed Corp的股票代码是什么?

IRadimed Corp的股票代码是IRMD。

IRadimed Corp股票的52周最高点是多少?

IRadimed Corp股票的52周最高点是98.240。

IRadimed Corp股票的52周最低点是多少?

IRadimed Corp股票的52周最低点是47.232。

IRadimed Corp的市值是多少?

IRadimed Corp的市值是1.23B。

IRadimed Corp的净利润是多少?

IRadimed Corp的净利润为19.23M。

现在IRadimed Corp(IRMD)的股票是买入、持有还是卖出?

根据分析师评级,IRadimed Corp(IRMD)的总体评级为买入,目标价格为99.000。

IRadimed Corp(IRMD)股票的每股收益(EPS TTM)是多少

IRadimed Corp(IRMD)股票的每股收益(EPS TTM)是1.667。
KeyAI